SHMT1 and SHMT2 inhibition disrupts metabolic adaptation in glioblastoma

Glioblastoma cells adapt to hypoxia and nutrient restriction through metabolic reprogramming. Serine hydroxymethyltransferases 1 and 2 (SHMT1, SHMT2) channel serine-derived one carbon units into folate metabolism, linking biosynthesis, respiration and redox defence. Its contribution to tumour metabolic homeostasis and adaptation to hypoxia and nutrient restriction remains unclear. We combined dual pharmacological SHMT inhibition using (+)-SHIN1 in glioblastoma cell lines, including patient-derived glioma stem-like models, with stable SHMT2 knockdown in LNT-229 cells. Functional analyses assessed clonogenic survival, invasion, migration and susceptibility to metabolic stress. Bioenergetics were measured by extracellular flux analysis and oxygen depletion, redox state by NADPH/NADP; assay, and molecular responses by liquid chromatography-mass spectrometry-based metabolomics and 13C6-glucose tracing and tandem mass tag proteomics. Formate supplementation tested the contribution of limited one-carbon availability, three-dimensional co-cultures with human induced pluripotent stem cell-derived embryoid bodies assessed tumour expansion, and in silico analyses of public glioblastoma datasets examined SHMT expression, regional distribution and associations with hypoxia-related genes. SHMT2 was enriched in hypoxic and perinecrotic tumour regions and correlated with hypoxia-inducible factor-1α target genes. SHMT inhibition impaired clonogenic growth, reduced invasion and migration, limited tumour expansion in co-culture, and sensitised cells to death under combined hypoxia and glucose restriction. Under normoxia, it increased respiration and estimates of glycolytic and oxidative ATP production. In G55T2 cells, SHMT inhibition lowered intracellular and extracellular lactate and altered tricarboxylic acid cycle metabolite levels and 13C isotopologue signals. SHMT inhibition increased oxidative stress, reduced the NADPH/NADP; ratio in a cell line- and condition-dependent manner, and reduced extracellular formate accumulation. In G55T2 cells, SHMT inhibition led to a depletion of glutathione. Formate supplementation most prominently restored invasion and partially reversed other antitumour effects of SHMT inhibition, with the extent of rescue varying between cell lines. Under combined stress, SHMT inhibition attenuated hypoxia-inducible factor-1-alpha; accumulation, an effect counteracted by formate supplementation. These findings link SHMT-dependent one-carbon metabolism to redox homeostasis, invasive behaviour and survival under metabolic stress in glioblastoma. SHMT inhibition increases respiratory activity under normoxia while compromising tolerance to combined oxygen and glucose restriction, identifying metabolic adaptation as a potential therapeutic vulnerability in glioblastoma.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.17.767126
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

SHMT1 and SHMT2 inhibition disrupts metabolic adaptation in glioblastoma

Lisa Hahnefeld, Michael W. Ronellenfitsch, Ann‐Christin Hau, Florian Straßheimer et al.
bioRxiv (Cold Spring Harbor Laboratory)
Cancer, Hypoxia, and Metabolism
preprint

SHMT1 and SHMT2 inhibition disrupts metabolic adaptation in glioblastoma

Lisa Hahnefeld, Michael W. Ronellenfitsch, Ann‐Christin Hau, Florian Straßheimer, Anna‐Luisa Luger, Irmgard Tegeder, Thorsten Mosler, Filip Hanak, Matthias Georg Schwab, Dmitry Namgaladze, Jan-Hendrik Schroeder, Joachim P. Steinbach, Mathias Haag, Sylvia Karin Neef, Leander F. Harwart, Hans Urban, Jan‐Béla Weinem, Tanja Buhlmann, Sven Koenig
preprint en

Abstract

Glioblastoma cells adapt to hypoxia and nutrient restriction through metabolic reprogramming. Serine hydroxymethyltransferases 1 and 2 (SHMT1, SHMT2) channel serine-derived one carbon units into folate metabolism, linking biosynthesis, respiration and redox defence. Its contribution to tumour metabolic homeostasis and adaptation to hypoxia and nutrient restriction remains unclear. We combined dual pharmacological SHMT inhibition using (+)-SHIN1 in glioblastoma cell lines, including patient-derived glioma stem-like models, with stable SHMT2 knockdown in LNT-229 cells. Functional analyses assessed clonogenic survival, invasion, migration and susceptibility to metabolic stress. Bioenergetics were measured by extracellular flux analysis and oxygen depletion, redox state by NADPH/NADP; assay, and molecular responses by liquid chromatography-mass spectrometry-based metabolomics and 13C6-glucose tracing and tandem mass tag proteomics. Formate supplementation tested the contribution of limited one-carbon availability, three-dimensional co-cultures with human induced pluripotent stem cell-derived embryoid bodies assessed tumour expansion, and in silico analyses of public glioblastoma datasets examined SHMT expression, regional distribution and associations with hypoxia-related genes. SHMT2 was enriched in hypoxic and perinecrotic tumour regions and correlated with hypoxia-inducible factor-1α target genes. SHMT inhibition impaired clonogenic growth, reduced invasion and migration, limited tumour expansion in co-culture, and sensitised cells to death under combined hypoxia and glucose restriction. Under normoxia, it increased respiration and estimates of glycolytic and oxidative ATP production. In G55T2 cells, SHMT inhibition lowered intracellular and extracellular lactate and altered tricarboxylic acid cycle metabolite levels and 13C isotopologue signals. SHMT inhibition increased oxidative stress, reduced the NADPH/NADP; ratio in a cell line- and condition-dependent manner, and reduced extracellular formate accumulation. In G55T2 cells, SHMT inhibition led to a depletion of glutathione. Formate supplementation most prominently restored invasion and partially reversed other antitumour effects of SHMT inhibition, with the extent of rescue varying between cell lines. Under combined stress, SHMT inhibition attenuated hypoxia-inducible factor-1-alpha; accumulation, an effect counteracted by formate supplementation. These findings link SHMT-dependent one-carbon metabolism to redox homeostasis, invasive behaviour and survival under metabolic stress in glioblastoma. SHMT inhibition increases respiratory activity under normoxia while compromising tolerance to combined oxygen and glucose restriction, identifying metabolic adaptation as a potential therapeutic vulnerability in glioblastoma.

bioRxiv (Cold Spring Harbor Laboratory)
Goethe University Frankfurt (DE), Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (DE), University Hospital Frankfurt (DE), University of Tübingen (DE)
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon